Pralidoxime Production Cost Reports

The report provides a detailed analysis essential for establishing a pralidoxime production plant. It encompasses all critical aspects necessary for pralidoxime production, including the cost of pralidoxime production, pralidoxime plant cost, pralidoxime production costs, and the overall pralidoxime production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a pralidoxime production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Pralidoxime is a cholinesterase reactivator that is used as an antidote for organophosphate poisoning from pesticides like malathion or parathion and nerve agents like sarin. It works by binding to the organophosphate attached to acetylcholinesterase. It displaces the phosphate group to restore enzyme function before irreversible "ageing" occurs, most effectively against diethoxy types but less so for dimethoxy organophosphates. It is administered via slow IV infusion, IM, or subcutaneously alongside atropine. It reverses respiratory muscle paralysis and nicotinic effects, and is also FDA-approved for anticholinesterase drug overdoses in conditions like myasthenia gravis. Its common side effects include pain at the injection site, blurred or double vision, headache, nausea, tachycardia, and hypertension, with optimal use early post-exposure.

The market for pralidoxime is fuelled by increasing organophosphate poisoning cases from pesticides and industrial exposures. The rise in awareness of its role as an antidote, regulatory mandates for national stockpiles, and enhancements in emergency medical infrastructure contribute to its market growth.

Its demand from the pharmaceutical sector, alongside military stockpiling, agricultural safety programs, and healthcare expansion, boosts its demand. The industrial pralidoxime procurement is affected by raw material constraints like pyridine derivatives sourced mainly from China and India. The limited shelf life necessitates cold chain logistics and varying global regulations that increase costs and complicate supply chains, further affecting its sourcing strategies. Other factors like government tenders, strategic alliances, and innovations like pre filled syringes prioritise further influence on its market dynamics.

Raw Material for Pralidoxime Production

According to the pralidoxime production plant project report, the key raw materials used in the production of pralidoxime include pyridine-2-carboxaldehyde, hydroxylamine hydrochloride, sodium acetate, and methyl iodide.

Production Process of Pralidoxime

The extensive pralidoxime production cost report consists of the following major industrial production process:

1. From pyridine-2-carboxaldehyde: The production process of pralidoxime involves three major steps. First, pyridine-2-carboxaldehyde reacts with hydroxylamine hydrochloride and sodium acetate in water to form the oxime intermediate. After that, this oxime goes through quaternisation with methyl iodide in methanol under reflux to yield the iodide salt. Then the iodide salt is converted to the chloride form, followed by recrystallisation to give pralidoxime as the final product.

Pralidoxime has the molecular formula of C7H9ClN2O, with a molecular weight of 172.61 g/mol. It appears as a white to pale yellow crystalline solid or powder, which is highly soluble in water. It is moderately soluble in alcohol and sparingly soluble in chloroform, with a logP value around 0.32, indicating moderate lipophilicity. It is stable under normal conditions but sensitive to light and heat. It features a pyridinium ring with a hydroxyimino methyl group, enabling nucleophilic attack on organophosphate-phosphorylated acetylcholinesterase. It has pKa values of around 8.0 (oxime) and 2.5 (pyridinium), supporting its ionic nature and reactivity in physiological pH.